# Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients

> **NCT01720043** · PHASE2 · TERMINATED · sponsor: **University of Utah** · enrollment: 8 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Velcade

## Key facts

- **NCT ID:** NCT01720043
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2015-04
- **Final completion:** 2017-07
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2017-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720043, "Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01720043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*